Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in Mixed Urinary Incontinence
NCT06769074Active, not recruiting
- Sponsor
- Zagazig University
- Start
- Dec 2024
- Primary completion
- Jun 2025
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous platelet-rich plasma in mixed urinary incontinence (MUI), sponsored by Zagazig University. Primary endpoint: Number of females with treatment-related improvement of mixed urinary incontinence at 6 months. Started Dec 2024; status: active, not recruiting.
02
Drugs
autologous platelet-rich plasma
03
Conditions
mixed urinary incontinence (MUI)
Beyond the preview
Go deeper on NCT06769074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06769074.